Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$1.80 USD

1.80
14,035,077

0.00 (0.00%)

Updated May 31, 2024 04:00 PM ET

After-Market: $1.80 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (48 out of 250)

Industry: Consumer Products - Staples

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Investors will focus on pipeline progress and updates, when Tilray (TLRY) reports first-quarter 2019 results.

Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Investors will focus on pipeline progress and updates, when Tilray (TLRY) reports first-quarter 2019 results.

Neena Mishra headshot

Marijuana ETFs Head-to-Head

by Neena Mishra

Here is what investors need to know about cannabis investing and the two ETFs that provide exposure to the space.

The Zacks Analyst Blog Highlights: Scott's Miracle Grow, GW Pharmaceuticals, Canopy Growth, Tilray and Aurora Cannabis

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Scott's Miracle Grow, GW Pharmaceuticals, Canopy Growth, Tilray and Aurora Cannabis

Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $46.40 in the latest trading session, marking a +0.76% move from the prior day.

Benjamin Rains headshot

Buy Marijuana Stocks, Tilray & Aurora Cannabis, Before Earnings?

by Benjamin Rains

The legal marijuana industry is still in the early stages, so let's see if investors should consider buying some pure-play marijuana stocks heading into earnings.

Tracey Ryniec headshot

5 Pot Stock Earnings Charts

by Tracey Ryniec

It's an emerging industry, but are companies actually beating on earnings?

Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $51.95, marking a +1.21% move from the previous day.

Zacks Value Trader Highlights: Novavax, J.C. Penney, Pier 1 Imports, Tilray and Aurora Cannabis

by Zacks Equity Research

Zacks Value Trader Highlights: Novavax, J.C. Penney, Pier 1 Imports, Tilray and Aurora Cannabis

Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $51.26 in the latest trading session, marking a +1.99% move from the prior day.

Tracey Ryniec headshot

Should You Buy Lottery Stocks?

by Tracey Ryniec

Like playing the lottery, some stocks lure in investors with the promise of possible riches.

Zacks Investment Ideas feature highlights: Canopy Growth, Tilray and Constellation Brands

by Zacks Equity Research

Zacks Investment Ideas feature highlights: Canopy Growth, Tilray and Constellation Brands

Sanghamitra Saha headshot

Likely Canopy-Acreage Deal Looks Good Enough to Boost ETF MJ

by Sanghamitra Saha

Canopy Growth will probably purchase the rights to buy Acreage Holdings to tap the growing potential of the U.S. marijuana market. This should bolster the ETF MJ.

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

by Zacks Equity Research

Tilray (TLRY) needs investors to pay close attention to the stock based on moves in the options market lately.

The Zacks Analyst Blog Highlights: Constellation Brand, Canopy Growth, Aurora Cannabis, Cronos and Tilray

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Constellation Brand, Canopy Growth, Aurora Cannabis, Cronos and Tilray

Daniel Laboe headshot

Constellation Makes Big Cannabis Bet

by Daniel Laboe

Constellation Brands have been continuously adding to their stake in Canopy Growth (CGC), which is the leading player in the Canadian cannabis market. STZ just added another $4 billion investment in August bringing its total stake in Canopy to 38% ownership.

Neena Mishra headshot

Best Performing ETFs of the First Quarter

by Neena Mishra

Major indexes posted their best quarterly performance since the financial crisis; here are some ETFs that soared during the quarter

Sweta Killa headshot

Short Sellers and Easing Rules Boost Pot ETF Higher

by Sweta Killa

Along with easing rules, short-selling of the stocks led to the spike in the pot ETF.

Nalak Das headshot

US Marijuana Industry to Flourish in 2019: Who Gains?

by Nalak Das

Legalization has long been considered a boon for the marijuana industry.

Sanghamitra Saha headshot

Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs

by Sanghamitra Saha

Tilray earnings results speak of bullishness, making things better for marijuana ETF investors.

Tilray, Inc. (TLRY) Flat As Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $70 in the latest trading session, marking no change from the prior day.

Athersys (ATHX) Q4 Earnings: What's in Store for the Stock?

by Zacks Equity Research

During Athersys' (ATHX) Q4 conference call, investor focus will be on the company's progress with its investigational MultiStem cell therapy to treat various indications.

Is a Beat in Store for Catabasis (CATB) This Earnings Season?

by Zacks Equity Research

Catabasis (CATB) progresses with DMD candidate, edasalonexent. However, operating expenses are likely to be lower.

What's in Store for BioSpecifics (BSTC) This Earnings Season?

by Zacks Equity Research

BioSpecifics (BSTC) is expected to provide updates on Xiaflex and its pipeline candidates in its fourth quarter earnings call.

What's in the Cards for Corbus (CRBP) This Earnings Season?

by Zacks Equity Research

Corbus (CRBP) is expected to provide updates on its pipeline candidates in the fourth quarter conference call.